Graham O'Keeffe

Returning to Work in a GMP Environment After Coronavirus

How to Avoid FDA Design Validation Warning Letters (21 CFR Part 820.30(g)) [Video]

How to Avoid FDA Data Integrity System Access Warning Letters (21 CFR Part 11) [Video]

How to Avoid FDA Design Change Warning Letters (21 CFR Part 820.30(i)) [Video]

How to Avoid FDA Laboratory Records Warning Letter (21 CFR 211.194(a)) [Video]

How to Avoid a FDA Quality Audit Warning Letter (21 CFR Part 820.22) [Video]

Your 1 Minute Guide to the Maintenance and Storage of Drug Labeling and Packaging – 21 CFR Part 211.22(c-d) [Video]

Your 1 Minute Recap of Equipment Cleaning and Use Log (Sect. 211.182)

Charge of Component and Preserving the Active Ingredient (Part 211.101) [Video]

How to Reduce the Spread of the Coronavirus [Video]